Comparison of carina-based versus bony anatomy-based registration for setup verification in esophageal cancer radiotherapy by Mélanie Machiels, Peng Jin, Christianne H. van Gurp, Jeanin E. van Hooft, Tanja Alderliesten, Maarten C. C. M. Hulshof

Get full text

Endoscopically placed fiducial markers for image-guided radiotherapy in preoperative gastric cancer: Technical feasibility and potential benefit by Margot Bleeker, Astrid van der Horst, Arjan Bel, Jan-Jakob Sonke, Jeanin E. van Hooft, R. E. Pouw, Maarten C.C.M. Hulshof

Get full text

Bladder-Sparing Chemoradiotherapy Combined with Immune Checkpoint Inhibition for Locally Advanced Urothelial Bladder Cancer—A Review by Jons W. van Hattum, Ben-Max de Ruiter, Jorg R. Oddens, Maarten C. C. M. Hulshof, Theo M. de Reijke, Adriaan D. Bins

Get full text

Microscopic tumor spread beyond (echo)endoscopically determined tumor borders in esophageal cancer by Melanie Machiels, Maurits L. van Montfoort, Nikki B. Thuijs, Mark I. van Berge Henegouwen, Tanja Alderliesten, Sybren L. Meijer, Jeanin E. van Hooft, Maarten C. C. M. Hulshof

Get full text

Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis by Tom van den Ende, Emil ter Veer, Rosa M. A. Mali, Mark I. van Berge Henegouwen, Maarten C. C. M. Hulshof, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven

Get full text

COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis by Tom van den Ende, Frank A. Abe Nijenhuis, Héctor G. van den Boorn, Emil ter Veer, Maarten C. C. M. Hulshof, Suzanne S. Gisbertz, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven

Get full text

The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysis by Tom van den Ende, Emil ter Veer, Mélanie Machiels, Rosa M. A. Mali, Frank A. Abe Nijenhuis, Laura de Waal, Marety Laarman, Suzanne S. Gisbertz, Maarten C. C. M. Hulshof, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven

Get full text

A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice by Ben-Max de Ruiter, Maaike W. van de Kamp, Jonah P.Z. van Steenbergen, Martine Franckena, Joost L. Boormans, Jeantine M. de Feijter, Adriaan D. Bins, Maarten C.C.M. Hulshof, Theo M. de Reijke, Eva Schaake, Jorg R. Oddens

Get full text

Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition by Tom van den Ende, Aiarpi Ezdoglian, Lisanne M. Baas, Joyce Bakker, Sinéad M. Lougheed, Micaela Harrasser, Cynthia Waasdorp, Mark I. van Berge Henegouwen, Maarten C.C.M. Hulshof, Nadia Haj Mohammad, Richard van Hillegersberg, Stella Mook, Conny J. van der Laken, Nicole C.T. van Grieken, Sarah Derks, Maarten F. Bijlsma, Hanneke W.M. van Laarhoven, Tanja D. de Gruijl

Get full text

Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies by Sanne J. M. Hoefnagel, Willem J. Koemans, Hina N. Khan, Jan Koster, Sybren L. Meijer, Jolanda M. van Dieren, Liudmila L. Kodach, Johanna W. van Sandick, Silvia Calpe, Carmen M. del Sancho-Serra, Ana C. P. Correia, Mark I. Van Berge Henegouwen, Suzanne S. Gisbertz, Maarten C. C. M. Hulshof, Sandro Mattioli, Manon C. W. Spaander, Kausilia K. Krishnadath

Get full text

Treatment decision‐making during outpatient clinic visit of patients with esophagogastric cancer. The perspectives of clinicians and patients, a mixed method, multiple case study by Josianne C. H. B. M. Luijten, Linda Brom, Pauline A. J. Vissers, Yes. A. J. van deWouw, Fabienne A. R. M. Warmerdam, Joos Heisterkamp, Stella Mook, Jamal Oulad Hadj, Marc J. vanDet, Liesbeth Timmermans, Maarten C. C. M. Hulshof, Hanneke W. M. vanLaarhoven, Camiel Rosman, Peter D. Siersema, Marjan J. Westerman, Rob H. A. Verhoeven, Grard A. P. Nieuwenhuijzen

Get full text

A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Respo... by Charlotte I. Stroes, Sandor Schokker, Remco J. Molenaar, Ron A. A. Mathôt, Maarten F. Bijlsma, Stephanie O. van der Woude, João P. Belo Pereira, Gerrit K. J. Hooijer, Rob H. A. Verhoeven, Annemieke Cats, Cecile Grootscholten, Johanna W. van Sandick, Geert-Jan Creemers, Grard A. P. Nieuwenhuijzen, Nadia Haj Mohammad, Jelle P. Ruurda, Sybren L. Meijer, Maarten C. C. M. Hulshof, Mark I. van Berge Henegouwen, Hanneke W. M. van Laarhoven

Get full text